secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001493152-25-013552
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO acquires Vector BioSource for $500K cash, Series E shares, and warrants
----------------------------------------------------------------------------

- Purchase price includes $500K cash, 60,000 Series E Preferred shares, and warrants for up to $2M common stock at 110% of pre-close price.
- Contingent earnout of up to 80,000 Series E shares if Vector achieves $4M qualifying revenue in year 2 after closing.
- Closing requires due diligence, final warrants/employment agreements, and 12-month budget with up to $1.2M funding.
- Sellers have limited right to repurchase shares at fair market value with a floor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225013552/0001493152-25-013552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225013552/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer